The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
ENZYME-STRUCTURE RELATIONSHIPS IN THE ENDOPLASMIC RETICULUM OF RAT LIVER
Ernster, L., Siekevitz, P., & Palade, G. E. (1962) · The Journal of Cell Biology · doi:10.1083/jcb.15.3.541 · Cited by 708
Andersson, T. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631010-00002 · Cited by 326
Self-citationStereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes
Äbelö, A., Andersson, T. B., Antonsson, M., Naudot, A. K., Skånberg, I., & Weidolf, L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15171-9 · Cited by 276
Self-citationPharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole
Andersson, T., Hassan-Alin, M., Hasselgren, G., R??hss, K., & Weidolf, L. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140060-00003 · Cited by 239
Self-citationIdentification of Human Liver Cytochrome P450 Isoforms Mediating Omeprazole Metabolism
ANDERSSON, T., MINERS, J. O., VERONESE, M. E., TASSANEEYAKUL, W., TASSANEEYAKUL, W., MEYER, U. A., & BIRKETT, D. J. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb00410.x · Cited by 230
Self-citationShirai, N., Furuta, T., Moriyama, Y., Okochi, H., Kobayashi, K., Takashima, M., Xiao, F., Kosuge, K., Nakagawa, K., Hanai, H., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01108.x · Cited by 221
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
Ko, J. W., Sukhova, N., Thacker, D. L., Chen, P., & Flockhart, D. A. (1997) · PubMed · Cited by 209
Andersson, T., Cederberg, C., Edvardsson, G., Heggelund, A., & Lundborg, P. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.12 · Cited by 165
Self-citationGugler, R., & Jensen, J. C. (1985) · PubMed · Cited by 164
Omeprazole inhibits oxidative drug metabolism
Gugler, R., & Jensen, J. C. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90638-9 · Cited by 158
Identification of the human P450 enzymes involved in lansoprazole metabolism.
Pearce, R. E., Rodrigues, A. D., Goldstein, J. A., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12938-8 · Cited by 148
Proton pump inhibitors: an update.
Vanderhoff, B., & Tahboub, R. (2002) · PubMed · Cited by 145
Yasuda, S., Horai, Y., Tomono, Y., Nakai, H., Yamato, C., Manabe, K., Kobayashi, K., Chiba, K., & Ishizaki, T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90192-2 · Cited by 137
Andersson, T., Holmberg, J., Rohss, K. M., & Walan, A. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.t01-1-00702.x · Cited by 125
Self-citationOmeprazole Drug Interaction Studies
Andersson, T. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121030-00004 · Cited by 123
Self-citationPharmacogenetics of the Proton Pump Inhibitors: A Systematic Review
Chong, E., & Ensom, M. H. H. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.4.460.32128 · Cited by 115
Drug Interaction Studies with Esomeprazole, the (S)-Isomer of Omeprazole
Andersson, T., Hassan‐Alin, M., Hasselgren, G., & hss, K. R. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00004 · Cited by 108
Self-citationInteraction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor
VandenBranden, M. R., Ring, B. J., Binkley, S. N., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00007 · Cited by 90
Sohn, D., Kwon, J., Kim, H.-K., & Ishizaki, T. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90137-5 · Cited by 89
Ishizaki, T., Chiba, K., Manabe, K., Koyama, E., Hayashi, M., Yasuda, S., Horai, Y., Tomono, Y., Yamato, C., & Toyoki, T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90193-0 · Cited by 81
Proton pump inhibitors - differences emerge in hepatic metabolism
MCCOLL, K. E. L., & Kennerley, P. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80102-5 · Cited by 74
Tanaka, Μ., Ohkubo, T., Otani, K., Suzuki, A., Kaneko, S., Sugawara, K., Ryokawa, Y., Hakusui, H., Yamamori, S., & Ishizaki, T. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90081-3 · Cited by 72
Lindberg, P., Keeling, D., Fryklund, J., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01481.x · Cited by 68
Influence of lansoprazole treatment on diazepam plasma concentrations
Lefebvre, R. A., Flouvat, B., Karolac-Tamisier, S., et al. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.172 · Cited by 64
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole
Furuta, S., Kamada, E., Suzuki, T., Sugimoto, T., Kawabata, Y., Shinozaki, Y., & Sano, H. (2001) · Xenobiotica · doi:10.1080/00498250110035615 · Cited by 58
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man
Gugler, R., HARTMANN, M., RUDI, J., et al. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.40619.x · Cited by 46
Drug Interactions with Antipsychotic Agents
ZumBrunnen, T. L., & Jann, M. W. (1998) · CNS Drugs · doi:10.2165/00023210-199809050-00005 · Cited by 32
Cytochrom-P450-Enzyme und ihre Bedeutung für Medikamenteninteraktionen
Papp-Jambor, C., Jaschinski, U., & Forst, H. (2002) · Der Anaesthesist · doi:10.1007/s101-002-8365-5 · Cited by 25
Pichard‐Garcia, L., Whomsley, R., Daujat‐Chavanieu, M., Maurel, P., Setoyama, T., & Humphries, T. J. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200020040-00006 · Cited by 10
Cited by
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
Juurlink, D. N., Gomes, T., Ko, D. T., Szmitko, P. E., Austin, P. C., Tu, J. V., Henry, D. A., Kopp, A., & Mamdani, M. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.082001 · Cited by 766
Metadata
- Authors
- Li, X.-Q., Andersson, T. B., Ahlström, M., & Weidolf, L.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 32
- Issue
- 8
- Pages
- 821-827
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2144766297
- Cited by
- 644
- References
- 30
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.